证券代码：000985 证券简称：大庆华科 公告编号：2023030 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 大庆华科股份有限公司（以下简称"公司"）第八届董事会任期 已经届满，根据《公司法》《证券法》《深圳证券交易所上市公司自 律监管指引第1号—主板上市公司规范运作》等法律、法规、规范性 文件及《公司章程》的规定，公司进行董事会换届选举工作。具体如 下： 一、非独立董事候选人的情况 公司于2023年8月25日召开第八届董事会第八次会议，审议通过 了《关于公司董事会换届选举暨提名第九届董事会非独立董事候选人 的议案》。经公司股东推荐，公司董事会提名委员会审议通过，公司 董事会提名王洪涛先生、窦岩先生、王威先生、贲涛先生、李崧延先 生、孟欣先生为公司第九届董事会非独立董事候选人（候选人简历详 见附件）。非独立董事候选人需提交公司2023年第二次临时股东大会 表决，任期自公司股东大会选举通过之日起三年。 二、独立董事候选人的情况 公司于2023年8月25日召开第八届董事会第八次会议，审议通过 了《关于公司董事会换届选举暨提名第九届董事会独立董事候选人的 议案》 ...

大庆华科股份有限公司 关于中油财务有限责任公司 1.注册地址：北京市东城区东直门北大街 9 号中国石油大厦 A 座 8 层-12 层 2.经营场所：北京市东城区东直门北大街 9 号中国石油大厦 A 座 8 层-12 层 3.金融许可证机构编码：L0003H211000001 4.统一社会信用代码：91110000100018558M 5.法定代表人：刘德 6.注册资本：1,639,527.31 万元，股东构成如下： | 序号 | 股东名称 | 出资额（万元） | 股权比例 | | --- | --- | --- | --- | | 1 | 中国石油天然气集团有限公司 | 655,810.92 | 40.00% | | 2 | 中国石油天然气股份有限公司 | 524,648.74 | 32.00% | | 3 | 中国石油集团资本有限责任公司 | 459,067.65 | 28.00% | | | 合 计 | 1,639,527.31 | 100.00% | 7.经营范围： 对成员单位办理财务和融资顾问、信用鉴证及相 关的咨询、代理业务；协助成员单位实现交易款项的收付；经批准的 保险代理业务；对成员单位提供担保 ...

附件 6 ②无控股股东、实际控制人的公司，存在第一大股东或第一大股东关联人非经营性占用资金的，也应填写本表非经营性占用部分。 上市公司 2023 年半年度非经营性资金占用及其他关联资金往来 情况汇总表 单位：万元 | 小计 | - | - | - | | | | | | | - | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 总计 | - | - | - | | | | | | | - | | 其他关联资金往来 | 资金往 | 往来方与上 | 上市公司核 | 2023 年期 | 2023 年度往 来累计发生 | 2023 年度 往来资金的 | 2023 年度 | 2023 年期 | 往来形 | 往来性质 （经营性往 | | | 来方名 | 市公司的关 | 算的会计科 | 初往来资 | | | 偿还累计发 | 末往来资金 | | | | | 称 | 联关系 | 目 | 金余额 | 金额（不含 | 利息（如 | 生金额 | 余额 | 成原因 | 来、非经营 | | | | | | | 利息） | 有） | | | | ...

证券代码： 000985 证券简称：大庆华科 公司将厘清各治理主体职责和边界，形成权责法定、权责透 明、协调运转、有效制衡的治理机制，保障各治理主体各司其职、 各负其责，促进公司的规范运作和健康发展。推进落实董事会中 长期发展决策权、经理层成员选聘权、经理层成员业绩考核权、 经理层成员薪酬管理权、职工工资分配管理权、重大财务事项管 理权等六项职权，有效促进董事会治理效率和行权履职能力大 幅，充分发挥董事会"定战略、作决策、防风险"的职能作用。 大庆华科股份有限公司投资者关系活动记录表 | 投资者关系活动 | □特定对象调研 分析师会议 □ | | --- | --- | | 类别 | 业绩说明会 □ 媒体采访 √ | | | □ 新闻发布会 □ 路演活动 | | | □ 现场参观 | | | □ 其他 （请文字说明其他活动内容） | | 参与单位名称及 | 投资者网上提问 | | 人员姓名 | | | 时间 | 2023 年 5 月 15 日 (周一) 下午 14:00~16:30 | | 地点 | 公司通过全景网"投资者关系互动平台"（https://ir.p5w.net） | | | 采用网络远程的方式召 ...

证券代码：000985 证券简称：大庆华科 公告编号：2023020 大庆华科股份有限公司 关于参加"2023 年投资者网上集体接待日 暨业绩说明会活动"的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，大庆华科股份有限公司（以 下简称"公司"）将参加由黑龙江证监局、黑龙江省上市公司协会与 深圳市全景网络有限公司联合举办的"2023 年黑龙江辖区上市公司 投资者集体接待日暨业绩说明会活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）；或关注微信公众号（名称：全景财经）； 或下载全景路演 APP,参与本次互动交流。活动时间为 2023 年 5 月 15 日（周一）14:00-16:30。届时公司财务总监武云峰女士，独立董事 王涌先生，董事会秘书孟凡礼先生将在线就公司 2022 年度业绩、公 司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等 投资者关心的问题，与投资者进行沟通与交流。 为充分尊重投资者、提升交流的针对性，现就公司本次 ...

证券代码：000985 证券简称：大庆华科 公告编号：2023020 大庆华科股份有限公司 关于参加"2023 年投资者网上集体接待日 暨业绩说明会活动"的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 为进一步加强与投资者的互动交流，大庆华科股份有限公司（以 下简称"公司"）将参加由黑龙江证监局、黑龙江省上市公司协会与 深圳市全景网络有限公司联合举办的"2023 年黑龙江辖区上市公司 投资者集体接待日暨业绩说明会活动"，现将相关事项公告如下： 本次活动将采用网络远程的方式举行，投资者可登录"全景路演" 网站（http://rs.p5w.net）；或关注微信公众号（名称：全景财经）； 或下载全景路演 APP,参与本次互动交流。活动时间为 2023 年 5 月 15 日（周一）14:00-16:30。届时公司财务总监武云峰女士，独立董事 王涌先生，董事会秘书孟凡礼先生将在线就公司 2022 年度业绩、公 司治理、发展战略、经营状况、融资计划、股权激励和可持续发展等 投资者关心的问题，与投资者进行沟通与交流。 为充分尊重投资者、提升交流的针对性，现就公司本次 ...

Financial Performance - The company's operating revenue for 2022 was ¥2,609,036,852.21, representing a 25.83% increase compared to ¥2,073,428,194.93 in 2021[6]. - The net profit attributable to shareholders for 2022 was ¥15,408,919.20, a 19.98% increase from ¥12,842,754.34 in 2021[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥11,958,066.78, up 25.25% from ¥9,547,556.30 in 2021[6]. - The basic and diluted earnings per share for 2022 were both ¥0.119, reflecting a 20.20% increase from ¥0.099 in 2021[6]. - The total operating revenue for 2022 was ¥2,609,036,852.21, representing a year-on-year increase of 27.11% from ¥2,073,428,194.93 in 2021[52]. - The gross profit margin for the chemical industry was 3.94%, a decrease of 1.92% compared to the previous year[53]. - The total operating cost increased by 28.40% to ¥2,506,206,934.63 from ¥1,951,879,305.00 in 2021[55]. - The company reported a significant decline in cash flow from operating activities, with a net outflow of ¥15,197,855.75 in 2022 compared to a net inflow of ¥63,163,053.33 in 2021, a decrease of 124.06%[6]. Shareholder Information - The company plans to distribute a cash dividend of 0.48 RMB per 10 shares to all shareholders, based on a total of 129,639,500 shares[6]. - The company reported a net profit of 15.41 million yuan for the period, with a total distributable profit of 110.35 million yuan[97]. - A cash dividend of 0.48 yuan per 10 shares was proposed, amounting to a total cash dividend of 6.22 million yuan, which represents 100% of the profit distribution[97]. - The company did not make any adjustments to its cash dividend policy during the reporting period[97]. Business Operations - The company has not changed its business scope during the reporting period, which includes the production and sales of fine chemical products and health food[17]. - The company has undergone several changes in its business scope since its establishment, with the latest change approved in 2015[17]. - The company is listed on the Shenzhen Stock Exchange under the stock code 000985[14]. - The company’s registered address is located in Daqing High-tech Industrial Development Zone, Heilongjiang Province[14]. - The company has designated China Securities Journal and Giant Tide Information Network as its official information disclosure media[5]. Market Outlook - The company anticipates a recovery in the petrochemical industry in 2023, with improved operating rates and profitability expected due to easing cost pressures[27]. - The company expects an overall increase in C5 resin consumption from 2023 to 2025, particularly in road marking paint and adhesives, driven by economic recovery[32]. - The company is focusing on high-value-added product development to enhance overall competitiveness and risk resistance in response to macroeconomic fluctuations[40]. Research and Development - The company has a stable R&D team of 68 members, with 34 senior engineers and 26 engineers[46]. - R&D expenses surged by 112.11% to ¥16,087,350.78 in 2022 from ¥7,584,466.29 in 2021, driven by increased R&D compensation[60]. - Total R&D investment rose by 29.08% to ¥92,377,895.31 in 2022 from ¥71,567,800.00 in 2021, representing 3.54% of operating revenue[61]. Environmental Compliance - The company is classified as a key pollutant discharge unit and adheres to relevant environmental protection laws and standards[106]. - The company invested a total of 6.0608 million yuan in environmental governance and protection during the reporting period[110]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[112]. - The company has established emergency response plans for environmental incidents, which have been reviewed by experts and filed with relevant authorities[108]. Corporate Governance - The company maintains a complete and independent governance structure, ensuring compliance with relevant laws and regulations[71]. - The company has established an independent financial department and accounting system, ensuring financial independence from its controlling shareholder[73]. - The company has a total of six independent directors, enhancing corporate governance and oversight[85]. - The company has established a remuneration and assessment committee responsible for evaluating senior management performance and determining compensation[86]. Financial Position - The total assets at the end of 2022 were ¥706,073,765.92, a slight increase of 0.09% from ¥705,436,187.12 at the end of 2021[6]. - The net assets attributable to shareholders at the end of 2022 were ¥603,170,642.04, up 1.84% from ¥592,292,056.90 at the end of 2021[6]. - The total liabilities decreased to ¥102,903,123.88 in 2022 from ¥113,144,130.22 in 2021, a reduction of 9.3%[159]. Related Party Transactions - The company reported a total of 262,889.82 million CNY in related party transactions, accounting for 71.79% of the approved transaction amount of 284,221 million CNY[123]. - The company engaged in raw material procurement from China National Petroleum Corporation Daqing Petrochemical Branch, with transaction value of 241,909.19 million CNY, representing 97.36% of similar transactions[123]. Management Changes - The company reported a significant management change, with the resignation of key personnel including the former General Manager Han Yuehui and several other executives due to work-related reasons[77]. - The current Chairman, Shi Tiequan, has a background in finance and has held various senior positions within the China National Petroleum Corporation[78]. - The new General Manager, Gong Xiangying, has been appointed and has extensive experience in the petrochemical industry[79]. Compliance and Risk Management - The company emphasizes compliance and risk prevention, establishing a robust internal control system[51]. - The internal control audit report received a standard unqualified opinion, confirming the effectiveness of the internal control system[103]. - The company has not encountered any major issues in the management and control of its subsidiaries during the reporting period[99].

Financial Performance - The company's operating revenue for Q1 2023 was ¥629,173,594.69, an increase of 2.02% compared to ¥616,709,642.53 in the same period last year[3] - Net profit attributable to shareholders decreased by 82.47% to ¥2,273,226.83 from ¥12,964,510.88 year-on-year[3] - The net profit after deducting non-recurring gains and losses fell by 86.83% to ¥1,623,668.20 from ¥12,329,026.83 in the previous year[3] - Basic and diluted earnings per share both decreased by 82.00% to ¥0.018 from ¥0.100 year-on-year[3] - The operating profit for Q1 2023 was CNY 2,621,587.62, down 82.8% from CNY 15,227,874.59 in Q1 2022[15] - The total comprehensive income for Q1 2023 was CNY 2,273,226.83, significantly lower than CNY 12,964,510.88 in Q1 2022[15] Cash Flow and Liquidity - Cash flow from operating activities improved significantly, reaching ¥23,254,404.49, compared to a negative cash flow of ¥5,052,681.00 in the same period last year, representing a 560.24% increase[3] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, compared to CNY 228,687,496.92 at the beginning of the year, indicating a growth of 8.3%[11] - The cash and cash equivalents at the end of Q1 2023 amounted to CNY 248,525,268.02, slightly down from CNY 250,194,369.72 at the end of Q1 2022[18] - The net cash flow from investing activities was CNY -3,416,633.39, compared to CNY -2,905,940.56 in Q1 2022[18] Assets and Liabilities - Total assets at the end of the reporting period were ¥723,240,713.05, an increase of 2.43% from ¥706,073,765.92 at the end of the previous year[3] - Total assets as of the end of Q1 2023 were CNY 723,240,713.05, an increase from CNY 706,073,765.92 at the beginning of the year[14] - Total liabilities increased to CNY 117,990,522.50 from CNY 102,903,123.88, representing a rise of 14.7%[13] Shareholder Information - The total number of common shareholders at the end of the reporting period was 10,031[6] - The largest shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 55.03% of the shares[6] - Shareholders' equity attributable to shareholders increased slightly by 0.34% to ¥605,250,190.55 from ¥603,170,642.04 at the end of the previous year[3] Operational Metrics - Total operating costs for Q1 2023 were CNY 622,783,990.80, up from CNY 601,545,404.03, reflecting a year-over-year increase of 3.7%[14] - Gross profit margin for Q1 2023 was approximately 1.6%, down from the previous year's margin[14] - Inventory at the end of Q1 2023 was CNY 140,404,795.13, up from CNY 126,991,745.34, reflecting an increase of 10.5%[12] - The company reported a decrease in accounts payable from CNY 26,368,633.96 to CNY 22,952,222.23, a reduction of 13.5%[13] Government Support and R&D - The company received government subsidies amounting to ¥711,392.82, with a net impact of ¥649,558.63 after tax considerations[5] - The company plans to continue focusing on research and development, with R&D expenses for Q1 2023 amounting to CNY 3,427,151.44, slightly down from CNY 3,677,702.08 in the previous year[14] Other Information - The company did not report any significant new product developments or market expansions during this quarter[15] - The company reported an asset impairment loss of CNY -4,571,967.06, compared to CNY -762,649.72 in the previous year[15] - Sales revenue from goods and services received cash of CNY 716,067,889.76, an increase from CNY 701,519,167.69 in the same period last year[17]

Financial Performance - The company's operating revenue for Q3 2022 was ¥712,125,992.19, representing a 31.92% increase year-over-year[3] - The net profit attributable to shareholders for the same period was ¥13,199,910.04, up 54.21% compared to the previous year[3] - The net profit after deducting non-recurring gains and losses reached ¥12,585,991.97, an increase of 81.55% year-over-year[3] - The basic earnings per share for Q3 2022 was ¥0.101, a 53.03% increase compared to the same period last year[3] - Total operating revenue for Q3 2022 reached CNY 2,042,605,504.47, an increase of 32.7% compared to CNY 1,538,693,303.11 in the same period last year[18] - Operating profit for the period was CNY 26,118,187.32, up 59.3% from CNY 16,380,921.66 in the previous year[18] - Net profit attributable to shareholders was CNY 22,226,240.07, representing a 70.5% increase from CNY 13,047,610.87 in the prior year[18] - Earnings per share (EPS) for the period was CNY 0.171, compared to CNY 0.101 in the same quarter last year, reflecting a 69.3% increase[19] Assets and Liabilities - The total assets at the end of the reporting period were ¥785,660,880.66, reflecting a 2.15% increase from the end of the previous year[3] - As of September 30, 2022, the total assets of Daqing Huake Co., Ltd. amounted to RMB 785,660,880.66, an increase from RMB 705,436,187.12 at the beginning of the year[15] - The total liabilities increased to CNY 169,539,955.96, up from CNY 113,144,130.22, indicating a growth of 49.8%[16] - Current liabilities amounted to CNY 121,629,532.81, significantly higher than CNY 63,082,053.24, marking a 93.1% increase[16] - The total equity attributable to shareholders increased to CNY 616,120,924.70, compared to CNY 592,292,056.90, reflecting a growth of 4.0%[16] Cash Flow - Cash flow from operating activities for the year-to-date was ¥98,502,496.05, down 26.17% compared to the previous year[3] - Cash inflow from operating activities totaled CNY 2,336,645,656.4, a rise of 31.4% from CNY 1,776,851,518.50 in the previous year[20] - The net cash flow from operating activities was 98,502,496.05, a decrease of 26.1% compared to 133,418,346.74 in the previous period[21] - The total cash outflow from operating activities amounted to 2,238,143,160.3, up from 1,643,433,171.76, indicating a significant increase in operational expenses[21] - The net cash flow from investing activities was -3,756,030.56, an improvement from -7,129,309.37 in the previous period, reflecting reduced investment losses[21] - The net cash flow from financing activities was -5,963,417.00, consistent with the previous period, indicating stable financing costs[21] - The ending balance of cash and cash equivalents was 346,936,039.77, slightly up from 340,206,551.85, indicating a stable liquidity position[21] Research and Development - Research and development expenses increased by 89.57% to ¥11,343,155.78 due to a rise in personnel involved in R&D[8] - Research and development expenses rose to CNY 11,343,155.78, up 89.5% from CNY 5,983,615.14 in the previous year[18] Shareholder Information - The company’s major shareholder, China National Petroleum Corporation, holds a 55.03% stake in the company[10] - The top shareholder, China Petroleum Daqing Petrochemical Co., Ltd., holds 71,339,700 shares, representing a significant portion of the company's equity[11] - The company has a total of 10,980,900 shares held by Daqing High-tech State-owned Assets Operation Co., Ltd., indicating strong institutional support[11] Other Information - The company has not disclosed any new product developments or technological advancements in the current report[12] - Future outlook and performance guidance were not explicitly detailed in the available documents[12] - The report for the third quarter was unaudited, which may affect the reliability of the financial data presented[22]

Financial Performance - The company's operating revenue for the first half of 2022 was approximately ¥1.33 billion, representing a 33.20% increase compared to ¥998.88 million in the same period last year[18]. - The net profit attributable to shareholders for the first half of 2022 was approximately ¥9.03 million, a significant increase of 101.12% from ¥4.49 million in the previous year[18]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was approximately ¥7.31 million, up 102.59% from ¥3.61 million year-on-year[18]. - The basic earnings per share for the first half of 2022 was ¥0.070, doubling from ¥0.035 in the same period last year[18]. - The company reported a net cash flow from operating activities of approximately ¥37.47 million, which is a 5.92% increase compared to ¥35.37 million in the previous year[18]. Assets and Liabilities - The company's total assets at the end of the reporting period were approximately ¥746.70 million, reflecting a 5.85% increase from ¥705.44 million at the end of the previous year[18]. - The net assets attributable to shareholders at the end of the reporting period were approximately ¥599.88 million, a slight increase of 1.28% from ¥592.29 million at the end of the previous year[18]. - Total liabilities reached RMB 146,816,702.24, an increase of 29.8% from RMB 113,144,130.22 at the beginning of the year[95]. - Non-current liabilities decreased slightly to RMB 48,626,879.70 from RMB 50,062,076.98, a decline of 2.9%[95]. Operational Focus - The company continues to focus on the production and sales of petrochemical products, with no significant changes in its main business operations[24]. - The company produces a variety of products including C5 and C9 petroleum resins, refined acetonitrile, and polypropylene, which are widely used in various industrial fields[24]. - The company is leveraging regional advantages to develop high-value-added products, promoting sustainable high-quality growth[31]. Research and Development - Research and development investment rose by 68.01% to ¥7,262,500.70, reflecting an increase in personnel and organizational adjustments[33]. - The company holds 13 national patents, including 8 invention patents, all of which have been industrialized, with core technologies for major products being proprietary[29]. - The company has a stable core management team and a professional R&D team of 68 members, enhancing its technological capabilities[28]. Sales and Market Presence - The sales network is well-established, with products exported to over 20 countries and regions, including Europe, Southeast Asia, and North America[31]. - Domestic sales accounted for 98.35% of total revenue, while international sales contributed 1.65%, showing a decline in foreign sales[35]. Environmental Compliance - The company has implemented measures to ensure compliance with environmental protection standards, including regular audits and pollution control facilities[55]. - The company has reported no significant violations of pollution discharge standards during the reporting period[56]. - The company received environmental impact assessment approval for the polypropylene unit bottleneck elimination project, which began trial production in November 2021 and is currently undergoing environmental completion acceptance[57]. - The company has implemented an environmental self-monitoring plan, with all monitoring data reported within permissible limits according to national standards[60]. Financial Management - The company has a deposit balance of 14,646 million CNY with Kunlun Bank, which is below the approved limit of 16,000 million CNY[74]. - The interest income from Kunlun Bank amounted to 143.99 million CNY, representing 62.10% of the total interest income from related parties[71]. - The company reported no significant related party transactions during the reporting period[72]. Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 13,439[84]. - China National Petroleum Daqing Oil Refining and Chemical Co., Ltd. holds 55.03% of the shares, totaling 71,339,700 shares[84]. - The largest shareholder, China National Petroleum Daqing Oil Refining and Chemical Co., Ltd., has no pledged or frozen shares[84]. Risk Factors - The company is facing risks from macroeconomic fluctuations and stricter energy policies, which may impact operational performance[42]. - The company plans to enhance its energy efficiency and reduce costs through technical upgrades and process improvements in response to rising energy prices[43]. Corporate Governance - The company has established a comprehensive internal control system to protect the interests of shareholders, particularly minority shareholders, and ensures timely and accurate information disclosure[62]. - The company has not engaged in any significant asset or equity sales during the reporting period[41]. - The company has not experienced any major safety incidents or environmental pollution events during the reporting period, with 14 safety inspections conducted by authorities[65].